The Science Policy Programme, established in 2011, examines concerns emerging from advances in scientific research, with an emphasis on the life sciences in Europe. We are focused on the governance of new technologies for advancing science, and the implications of the use of these new technologies for the public.
Our major areas of interest are biotechnology and genomic technologies; research integrity; and scientific publishing with respect to open access, the usability of data underlying publications, and the reproducibility of the scientific literature.
Our aim is to provide informed analyses to policymakers and other policy leaders, research administrators, and scientists for use in their decision-making processes.
We conduct our work through policy research, including technology assessment. We engage EMBO Members, individuals and offices at the European level, and staff of other EMBO Programmes. We are also involved in a wide range of European and international projects.
The Science Policy programme also offers a limited number of lecture grants to scientific event organizers wishing to include a non-scientific lecture addressing the policy implications of science and technology in their programme.
The Science Policy Programme is always happy to hear from the community with questions, concerns, or ideas about science policy.